Determining appropriate protein intake for patients taking semaglutide requires consideration of multiple factors, including baseline body weight, weight loss goals, activity level, and individual tolerance
In semaglutides 68-week trial, half of the participants lost 15% of their body weight, while one-third lost 20%
Record the date of first use on the bottle label
This means they bind to the GLP-1 receptors in your body to suppress your appetite, limit food cravings, and promote weight loss
Tirzepatide sometimes decreases thirst signals, which can cause dehydration to feel like hunger
These changes persist for years after weight loss, possibly indefinitely